Abstract OT3-08-01: A phase 1 trial of LOXO-783, a potent, highly mutant-selective, brain-penetrant allosteric PI3Kα H1047R inhibitor in PIK3CA H1047R-mutant advanced breast cancer (aBC) and other solid tumors (PIKASSO-01, trial in progress)Dejan Juric, Funda Meric‐Bernstam, Vincent Chau et al.|Cancer Research|2023Cited by 9
Abstract PS7-03: A first-in-human phase 1a/b trial of LOXO-783, a potent, highly mutant-selective, brain-penetrant, allosteric PI3Kα H1047R inhibitor in PIK3CA H1047R-mutant advanced breast cancer and other solid tumors: Results from the PIKASSO-01 studyKomal Jhaveri, Funda Meric-Bernstam, Takako Eguchi Nakajima et al.|Clinical Cancer Research|2025Cited by 2
The Role of One-Carbon Metabolism in the Development and Prevention of Colorectal CancerMatthew P. Hanley|OpenCommons - UConn (University of Connecticut)|2016Cited by 0